SIMILAR PATTERNS OF AMINO ACIDS FOR 3NUJ_B_478B401

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bu8 PROTEIN (PANCREATIC
LIPASE RELATED
PROTEIN 2)


(Rattus
norvegicus)
PF00151
(Lipase)
PF01477
(PLAT)
5 ALA A 161
VAL A 124
GLY A 150
ILE A 149
ILE A 128
None
1.01A 3nujA-1bu8A:
undetectable
3nujA-1bu8A:
13.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ga8 GALACTOSYL
TRANSFERASE LGTC


(Neisseria
meningitidis)
PF01501
(Glyco_transf_8)
5 ASP A   2
VAL A   4
ILE A  93
GLY A  90
ILE A 169
None
0.92A 3nujA-1ga8A:
undetectable
3nujA-1ga8A:
13.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gae D-GLYCERALDEHYDE-3-P
HOSPHATE
DEHYDROGENASE


(Escherichia
coli)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA O  19
VAL O   3
ILE O 325
ILE O  11
ILE O  27
None
None
None
NAD  O 336 (-3.9A)
None
0.91A 3nujA-1gaeO:
undetectable
3nujA-1gaeO:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gzg DELTA-AMINOLEVULINIC
ACID DEHYDRATASE


(Pseudomonas
aeruginosa)
PF00490
(ALAD)
5 ALA A  82
VAL A 171
GLY A 320
ILE A 321
ILE A 125
None
0.97A 3nujA-1gzgA:
undetectable
3nujA-1gzgA:
16.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.62A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.62A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  48
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-4.1A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
1.00A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-3.6A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.83A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 ( 3.9A)
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
0.47A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.3A)
A79  A 800 ( 3.4A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 ( 3.4A)
A79  A 800 (-4.5A)
A79  A 800 (-3.8A)
0.48A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  30
VAL A  32
ILE A  47
GLY A  51
VAL A  82
ILE A  84
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.2A)
None
A79  A 800 (-4.5A)
A79  A 800 (-3.6A)
1.21A 3nujA-1hvcA:
14.0
3nujA-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ik6 PYRUVATE
DEHYDROGENASE


(Pyrobaculum
aerophilum)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 ILE A  67
GLY A  69
PRO A  81
VAL A  29
ILE A  58
None
0.99A 3nujA-1ik6A:
undetectable
3nujA-1ik6A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kkm HPRK PROTEIN

(Lactobacillus
casei)
PF07475
(Hpr_kinase_C)
5 VAL A 260
ILE A 191
GLY A 193
ILE A 176
ILE A 231
None
1.00A 3nujA-1kkmA:
undetectable
3nujA-1kkmA:
24.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1olx 2-OXOISOVALERATE
DEHYDROGENASE BETA
SUBUNIT


(Homo sapiens)
PF02779
(Transket_pyr)
PF02780
(Transketolase_C)
5 ALA B 226
ASP B 253
ILE B 326
VAL B 237
ILE B 234
None
0.91A 3nujA-1olxB:
undetectable
3nujA-1olxB:
16.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
ILE A  84
None
0.68A 3nujA-1q9pA:
10.0
3nujA-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
None
0.64A 3nujA-1sivA:
18.6
3nujA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
None
0.86A 3nujA-1sivA:
18.6
3nujA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.21A 3nujA-1sivA:
18.6
3nujA-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cev PROTEIN (ARGINASE)

([Bacillus]
caldovelox)
PF00491
(Arginase)
5 ALA A 110
VAL A 118
GLY A 104
ILE A 157
ILE A 164
None
0.99A 3nujA-2cevA:
undetectable
3nujA-2cevA:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dpl GMP SYNTHASE
[GLUTAMINE-HYDROLYZI
NG] SUBUNIT B


(Pyrococcus
horikoshii)
PF00958
(GMP_synt_C)
PF02540
(NAD_synthase)
5 ALA A 232
VAL A 293
ILE A 279
VAL A 290
ILE A 253
None
1.02A 3nujA-2dplA:
undetectable
3nujA-2dplA:
15.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  54
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
LP1  A 201 (-3.6A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
1.04A 3nujA-2fmbA:
15.0
3nujA-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
8 ASP A  25
ALA A  28
VAL A  32
ILE A  53
GLY A  55
PRO A  86
VAL A  87
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-4.6A)
LP1  A 201 (-3.4A)
LP1  A 201 (-3.9A)
LP1  A 201 ( 4.9A)
LP1  A 201 (-4.2A)
0.47A 3nujA-2fmbA:
15.0
3nujA-2fmbA:
34.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2glw 92AA LONG
HYPOTHETICAL PROTEIN


(Pyrococcus
horikoshii)
no annotation 5 ALA A  54
GLY A  60
ILE A  18
VAL A  82
ILE A  37
None
1.02A 3nujA-2glwA:
undetectable
3nujA-2glwA:
24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gm5 TRANSPOSON
GAMMA-DELTA
RESOLVASE


(Escherichia
coli)
PF00239
(Resolvase)
5 ALA A  26
ASP A  25
GLY A   5
ILE A  61
ILE A  93
None
1.00A 3nujA-2gm5A:
undetectable
3nujA-2gm5A:
23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hc8 CATION-TRANSPORTING
ATPASE, P-TYPE


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.91A 3nujA-2hc8A:
undetectable
3nujA-2hc8A:
26.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hwy PROTEIN SMG5

(Homo sapiens)
PF13638
(PIN_4)
5 VAL A 882
ILE A 871
GLY A 905
ILE A 906
ILE A 920
None
1.03A 3nujA-2hwyA:
undetectable
3nujA-2hwyA:
19.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ki7 RIBONUCLEASE P
PROTEIN COMPONENT 1


(Pyrococcus
furiosus)
PF01868
(UPF0086)
5 ASP A  72
VAL A  70
GLY A 110
ILE A  95
ILE A  80
None
0.97A 3nujA-2ki7A:
undetectable
3nujA-2ki7A:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.78A 3nujA-2p3eA:
undetectable
3nujA-2p3eA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q0l THIOREDOXIN
REDUCTASE


(Helicobacter
pylori)
PF07992
(Pyr_redox_2)
5 ALA A   5
VAL A  84
ILE A 108
GLY A   8
ILE A  93
None
None
None
FAD  A 400 (-3.2A)
None
0.90A 3nujA-2q0lA:
undetectable
3nujA-2q0lA:
15.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r7m 5-FORMAMINOIMIDAZOLE
-4-CARBOXAMIDE-1-(BE
TA)-D-RIBOFURANOSYL
5'-MONOPHOSPHATE
SYNTHETASE


(Methanocaldococcus
jannaschii)
PF06849
(DUF1246)
PF06973
(DUF1297)
5 ILE A   7
ILE A 291
PRO A  91
VAL A  90
ILE A  88
None
1.02A 3nujA-2r7mA:
undetectable
3nujA-2r7mA:
15.84
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.52A 3nujA-2rkfA:
20.8
3nujA-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-4.2A)
AB1  A 501 ( 4.2A)
0.52A 3nujA-2rkfA:
20.8
3nujA-2rkfA:
82.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2v5i SALMONELLA
TYPHIMURIUM DB7155
BACTERIOPHAGE DET7
TAILSPIKE


(unidentified
phage)
PF09251
(PhageP22-tail)
5 ALA A 548
ILE A 580
ILE A 536
VAL A 543
ILE A 546
None
0.87A 3nujA-2v5iA:
undetectable
3nujA-2v5iA:
12.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wqd PHOSPHOENOLPYRUVATE-
PROTEIN
PHOSPHOTRANSFERASE


(Staphylococcus
aureus)
PF00391
(PEP-utilizers)
PF02896
(PEP-utilizers_C)
PF05524
(PEP-utilisers_N)
6 ASP A 228
VAL A 229
ILE A 204
GLY A 206
ILE A 185
ILE A   5
None
1.42A 3nujA-2wqdA:
undetectable
3nujA-2wqdA:
11.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y23 MYOMESIN

(Homo sapiens)
PF07679
(I-set)
5 ASP A1401
GLY A1409
ILE A1410
VAL A1428
ILE A1389
None
0.85A 3nujA-2y23A:
undetectable
3nujA-2y23A:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y6p 3-DEOXY-MANNO-OCTULO
SONATE
CYTIDYLYLTRANSFERASE


(Aquifex
aeolicus)
PF02348
(CTP_transf_3)
5 ASP A 103
VAL A  99
ILE A 104
ILE A   6
VAL A  33
None
1.02A 3nujA-2y6pA:
undetectable
3nujA-2y6pA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fkj PUTATIVE
PHOSPHOSUGAR
ISOMERASES


(Salmonella
enterica)
PF01380
(SIS)
5 ALA A  99
ILE A  75
GLY A 102
ILE A 118
ILE A  15
None
0.74A 3nujA-3fkjA:
undetectable
3nujA-3fkjA:
13.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i1i HOMOSERINE
O-ACETYLTRANSFERASE


(Bacillus
anthracis)
PF00561
(Abhydrolase_1)
5 ALA A  54
VAL A  85
GLY A  70
ILE A 355
ILE A  44
None
0.85A 3nujA-3i1iA:
undetectable
3nujA-3i1iA:
12.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ ALPHA CHAIN
ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ BETA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 ASP B 241
ILE A 130
GLY A 128
PRO A  64
VAL A  65
None
0.93A 3nujA-3it4B:
undetectable
3nujA-3it4B:
17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j08 COPPER-EXPORTING
P-TYPE ATPASE A


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
PF00702
(Hydrolase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.96A 3nujA-3j08A:
undetectable
3nujA-3j08A:
9.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j09 COPPER-EXPORTING
P-TYPE ATPASE A


(Archaeoglobus
fulgidus)
PF00122
(E1-E2_ATPase)
PF00403
(HMA)
PF00702
(Hydrolase)
5 ASP A 288
VAL A 290
ILE A 250
PRO A 258
VAL A 259
None
0.97A 3nujA-3j09A:
undetectable
3nujA-3j09A:
8.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3la4 UREASE

(Canavalia
ensiformis)
PF00449
(Urease_alpha)
PF00547
(Urease_gamma)
PF00699
(Urease_beta)
PF01979
(Amidohydro_1)
5 ALA A 355
VAL A 399
ILE A 341
GLY A 358
ILE A 346
None
0.96A 3nujA-3la4A:
undetectable
3nujA-3la4A:
9.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mst PUTATIVE NITRATE
TRANSPORT PROTEIN


(Thermoplasma
volcanium)
PF12916
(DUF3834)
6 ALA A 171
ILE A 163
GLY A 191
ILE A 192
PRO A  10
ILE A 174
None
None
None
None
ACT  A 232 (-4.6A)
None
1.16A 3nujA-3mstA:
undetectable
3nujA-3mstA:
18.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
10 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
VAL A  82
ILE A  84
None
0.55A 3nujA-3mwsA:
20.2
3nujA-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
GLY A  48
PRO A  81
VAL A  82
ILE A  84
None
0.92A 3nujA-3mwsA:
20.2
3nujA-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p24 BFT-3

(Bacteroides
fragilis)
PF13583
(Reprolysin_4)
PF16376
(fragilysinNterm)
6 ALA A 332
VAL A 222
GLY A 351
ILE A 385
VAL A 220
ILE A 300
None
1.48A 3nujA-3p24A:
undetectable
3nujA-3p24A:
13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
5 ASP A  32
ALA A  35
VAL A  39
GLY A  56
PRO A  89
3TL  A 126 (-2.4A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
3TL  A 126 (-4.0A)
0.88A 3nujA-3slzA:
11.2
3nujA-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3stj PROTEASE DEGQ

(Escherichia
coli)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 ALA A 102
VAL A  29
ILE A  84
VAL A  27
ILE A  92
None
1.00A 3nujA-3stjA:
undetectable
3nujA-3stjA:
14.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
VAL A  32
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
None
0.77A 3nujA-3t3cA:
18.4
3nujA-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
ILE A  50
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.83A 3nujA-3t3cA:
18.4
3nujA-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
VAL A  32
ILE A  47
GLY A  49
PRO A  81
017  A 201 (-2.6A)
017  A 201 (-3.5A)
None
None
017  A 201 (-4.0A)
None
0.98A 3nujA-3t3cA:
18.4
3nujA-3t3cA:
75.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tdg PUTATIVE
UNCHARACTERIZED
PROTEIN


(Helicobacter
pylori)
no annotation 6 ASP A  68
VAL A  47
GLY A  88
ILE A  87
VAL A  38
ILE A  39
None
1.40A 3nujA-3tdgA:
undetectable
3nujA-3tdgA:
16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsn 4-HYDROXYTHREONINE-4
-PHOSPHATE
DEHYDROGENASE


(Campylobacter
jejuni)
PF04166
(PdxA)
5 ALA A  44
ILE A   8
GLY A  15
ILE A  14
ILE A  96
None
1.00A 3nujA-3tsnA:
undetectable
3nujA-3tsnA:
13.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.1A)
017  A 201 (-4.7A)
0.67A 3nujA-3ttpA:
19.7
3nujA-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
ILE A  47
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-3.6A)
017  A 202 (-4.0A)
0.63A 3nujA-3u7sA:
19.9
3nujA-3u7sA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 ASP A  25
ALA A  28
ILE A  47
GLY A  49
ILE A  50
PRO A  81
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 202 (-3.6A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
017  A 202 (-4.0A)
0.71A 3nujA-3u7sA:
19.9
3nujA-3u7sA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w64 MAGNETOSOME PROTEIN
MAMM


(Magnetospirillum
gryphiswaldense)
PF16916
(ZT_dimer)
5 ALA A 248
VAL A 274
ILE A 251
VAL A 222
ILE A 221
None
1.01A 3nujA-3w64A:
undetectable
3nujA-3w64A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w8g MAGNETOSOME PROTEIN
MAMM


(Magnetospirillum
gryphiswaldense)
PF16916
(ZT_dimer)
5 ALA A 248
VAL A 274
ILE A 251
VAL A 222
ILE A 221
None
0.98A 3nujA-3w8gA:
undetectable
3nujA-3w8gA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zuz PROTEIN SHQ1

(Saccharomyces
cerevisiae)
PF04925
(SHQ1)
5 ALA A 409
ILE A 271
GLY A 402
VAL A 252
ILE A 251
None
1.02A 3nujA-3zuzA:
undetectable
3nujA-3zuzA:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ao7 ESTERASE

(unidentified)
PF12146
(Hydrolase_4)
5 ALA A 125
VAL A  31
ILE A 119
PRO A  82
ILE A  79
None
0.89A 3nujA-4ao7A:
undetectable
3nujA-4ao7A:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bed HEMOCYANIN KLH1

(Megathura
crenulata)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
5 ALA B2984
ASP B3152
ILE B2979
ILE B3104
ILE B2942
None
0.94A 3nujA-4bedB:
undetectable
3nujA-4bedB:
4.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d7e L-LYS MONOOXYGENASE

(Nocardia
farcinica)
PF13434
(K_oxygenase)
5 ALA A  17
VAL A 124
ILE A  66
ILE A  82
ILE A 128
None
0.97A 3nujA-4d7eA:
undetectable
3nujA-4d7eA:
13.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4doi CHALCONE--FLAVONONE
ISOMERASE 1


(Arabidopsis
thaliana)
PF02431
(Chalcone)
5 VAL A  63
ILE A 203
GLY A 207
VAL A 106
ILE A 104
None
None
None
NO3  A 301 (-4.8A)
None
1.01A 3nujA-4doiA:
undetectable
3nujA-4doiA:
19.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fln PROTEASE DO-LIKE 2,
CHLOROPLASTIC


(Arabidopsis
thaliana)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 ASP A 218
VAL A 220
ILE A 280
ILE A 299
ILE A 259
None
1.02A 3nujA-4flnA:
undetectable
3nujA-4flnA:
12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g7e UREASE

(Cajanus cajan)
PF00449
(Urease_alpha)
PF00547
(Urease_gamma)
PF00699
(Urease_beta)
PF01979
(Amidohydro_1)
5 ALA B 355
VAL B 399
ILE B 341
GLY B 358
ILE B 346
None
0.91A 3nujA-4g7eB:
undetectable
3nujA-4g7eB:
8.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gt6 CELL SURFACE PROTEIN

(Faecalibacterium
prausnitzii)
PF13306
(LRR_5)
6 ALA A 355
ILE A 342
ILE A 325
PRO A 368
VAL A 371
ILE A 351
None
1.36A 3nujA-4gt6A:
undetectable
3nujA-4gt6A:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j5u SERINE
HYDROXYMETHYLTRANSFE
RASE


(Rickettsia
rickettsii)
PF00464
(SHMT)
5 ALA A 173
ASP A 201
VAL A 224
ILE A 202
PRO A 219
None
LLP  A 230 ( 2.9A)
None
None
None
0.99A 3nujA-4j5uA:
undetectable
3nujA-4j5uA:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kxr ESPG5

(Mycobacterium
tuberculosis)
PF14011
(ESX-1_EspG)
5 VAL C 139
ILE C 137
GLY C  16
VAL C  71
ILE C  10
None
0.88A 3nujA-4kxrC:
undetectable
3nujA-4kxrC:
14.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mde METALLOPHOSPHOESTERA
SE


(Ruminiclostridium
thermocellum)
PF13671
(AAA_33)
5 VAL A 105
ILE A 141
GLY A 143
VAL A  12
ILE A  14
None
1.03A 3nujA-4mdeA:
undetectable
3nujA-4mdeA:
18.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 ( 4.5A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.45A 3nujA-4njvA:
21.0
3nujA-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
RIT  A 500 (-3.9A)
RIT  A 500 (-4.3A)
0.83A 3nujA-4njvA:
21.0
3nujA-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nqy ISOPROPYLMALATE/CITR
AMALATE ISOMERASE
LARGE SUBUNIT


(Methanocaldococcus
jannaschii)
PF00330
(Aconitase)
5 VAL A 177
ILE A 164
GLY A 166
VAL A 172
ILE A 272
None
0.90A 3nujA-4nqyA:
undetectable
3nujA-4nqyA:
12.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p80 ANCESTRAL PYRR
PROTEIN (GREEN)


(synthetic
construct)
PF00156
(Pribosyltran)
5 ASP A   9
ILE A  13
GLY A 150
ILE A 149
VAL A 161
None
0.94A 3nujA-4p80A:
undetectable
3nujA-4p80A:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p8r GLYCERALDEHYDE
3-PHOSPHATE
DEHYDROGENASE,
CYTOSOLIC


(Trypanosoma
brucei)
PF00044
(Gp_dh_N)
PF02800
(Gp_dh_C)
5 ALA A  21
VAL A   5
ILE A 326
ILE A  13
ILE A  29
MG  A 401 (-4.5A)
None
None
NAD  A 400 (-4.3A)
None
0.92A 3nujA-4p8rA:
undetectable
3nujA-4p8rA:
16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pfq HYPOXANTHINE
PHOSPHORIBOSYLTRANSF
ERASE


(Brachybacterium
faecium)
PF00156
(Pribosyltran)
5 ASP A  39
VAL A 197
ILE A  43
GLY A 172
ILE A 171
None
1.01A 3nujA-4pfqA:
undetectable
3nujA-4pfqA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4twb RIBOSE-PHOSPHATE
PYROPHOSPHOKINASE


(Sulfolobus
solfataricus)
PF00156
(Pribosyltran)
PF13793
(Pribosyltran_N)
5 ASP A 217
ILE A 245
GLY A 267
ILE A 279
ILE A 215
None
1.02A 3nujA-4twbA:
undetectable
3nujA-4twbA:
17.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
5 ASP A  32
ALA A  35
VAL A  39
GLY A  58
ILE A 100
4B1  A 201 (-2.9A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.34A 3nujA-4ydfA:
13.0
3nujA-4ydfA:
32.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ywl CELL DIVISION
CONTROL PROTEIN 21


(Pyrococcus
furiosus)
PF14551
(MCM_N)
PF17207
(MCM_OB)
6 VAL A 221
ILE A 187
GLY A 205
ILE A 206
VAL A 214
ILE A 249
None
0.94A 3nujA-4ywlA:
undetectable
3nujA-4ywlA:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a6s ENDOLYSIN

(Clostridium
phage phiCTP1)
PF01183
(Glyco_hydro_25)
5 ASP A   6
ILE A 181
ILE A 142
VAL A  90
ILE A  28
SO4  A1274 (-4.0A)
None
None
None
None
0.97A 3nujA-5a6sA:
undetectable
3nujA-5a6sA:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bwi GLYCOSIDE HYDROLASE
FAMILY 79


(Burkholderia
pseudomallei)
PF12891
(Glyco_hydro_44)
5 ALA A 330
ASP A 444
ILE A 324
VAL A 364
ILE A 362
None
0.92A 3nujA-5bwiA:
undetectable
3nujA-5bwiA:
13.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5chc DMSO REDUCTASE
FAMILY TYPE II
ENZYME,
MOLYBDOPTERIN
SUBUNIT


(Azospira oryzae)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
5 ALA A 809
ILE A 817
GLY A 846
PRO A 787
ILE A 789
None
0.99A 3nujA-5chcA:
undetectable
3nujA-5chcA:
8.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cvc SERINE RACEMASE

(Zea mays)
PF00291
(PALP)
5 VAL A 201
ILE A 320
GLY A 296
VAL A 263
ILE A 198
None
1.00A 3nujA-5cvcA:
undetectable
3nujA-5cvcA:
13.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d3m ENERGY-COUPLING
FACTOR TRANSPORTER
ATP-BINDING PROTEIN
ECFA1


(Lactobacillus
delbrueckii)
PF00005
(ABC_tran)
5 ALA A 153
GLY A  87
ILE A 166
VAL A 186
ILE A 154
None
1.02A 3nujA-5d3mA:
undetectable
3nujA-5d3mA:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ees 4-HYDROXY-TETRAHYDRO
DIPICOLINATE
REDUCTASE


(Corynebacterium
glutamicum)
PF01113
(DapB_N)
PF05173
(DapB_C)
5 ALA A 222
VAL A  22
GLY A 228
VAL A   7
ILE A  18
None
1.01A 3nujA-5eesA:
undetectable
3nujA-5eesA:
14.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eg6 RECOMBINING BINDING
PROTEIN SUPPRESSOR
OF HAIRLESS


(Mus musculus)
PF09270
(BTD)
PF09271
(LAG1-DNAbind)
5 VAL C  99
GLY C 130
ILE C 131
PRO C  97
ILE C  76
None
None
BU1  C 521 (-4.7A)
None
None
1.02A 3nujA-5eg6C:
undetectable
3nujA-5eg6C:
14.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5epa SNOK

(Streptomyces
nogalater)
PF05721
(PhyH)
5 VAL A 201
ILE A  88
GLY A  90
VAL A  27
ILE A  29
None
0.82A 3nujA-5epaA:
undetectable
3nujA-5epaA:
15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f15 4-AMINO-4-DEOXY-L-AR
ABINOSE (L-ARA4N)
TRANSFERASE


(Cupriavidus
metallidurans)
PF13231
(PMT_2)
5 ALA A 145
GLY A 291
ILE A 290
VAL A 349
ILE A 350
None
MPG  A 625 ( 3.7A)
MPG  A 625 ( 4.6A)
None
None
0.99A 3nujA-5f15A:
undetectable
3nujA-5f15A:
10.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hsp MAGNETOSOME PROTEIN
MAMM


(Magnetospirillum
gryphiswaldense)
PF16916
(ZT_dimer)
5 ALA A 248
VAL A 274
ILE A 251
VAL A 222
ILE A 221
None
1.00A 3nujA-5hspA:
undetectable
3nujA-5hspA:
16.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ijl DNA POLYMERASE II
LARGE SUBUNIT


(Pyrococcus
abyssi)
PF03833
(PolC_DP2)
6 ASP A  46
ALA A  48
VAL A  68
ILE A 109
GLY A 113
ILE A 114
None
1.30A 3nujA-5ijlA:
undetectable
3nujA-5ijlA:
7.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ilb PROTEASE DO-LIKE 2,
CHLOROPLASTIC,PROTEA
SE DO-LIKE 9


(Arabidopsis
thaliana)
PF13180
(PDZ_2)
PF13365
(Trypsin_2)
5 ASP A 218
VAL A 220
ILE A 280
ILE A 299
ILE A 259
None
0.99A 3nujA-5ilbA:
undetectable
3nujA-5ilbA:
13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4l CERULOPLASMIN

(Rattus
norvegicus)
no annotation 5 ALA A 102
VAL A  88
ILE A  78
GLY A 175
ILE A 174
None
0.95A 3nujA-5n4lA:
undetectable
3nujA-5n4lA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nil MACROLIDE EXPORT
ATP-BINDING/PERMEASE
PROTEIN MACB


(Escherichia
coli)
PF00005
(ABC_tran)
PF02687
(FtsX)
PF12704
(MacB_PCD)
5 ALA J 529
VAL J 290
GLY J 282
ILE J 281
ILE J 289
None
1.01A 3nujA-5nilJ:
3.9
3nujA-5nilJ:
9.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 ASP A  25
ALA A  28
ASP A  30
VAL A  32
ILE A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
None
0.69A 3nujA-5t2zA:
20.1
3nujA-5t2zA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tc4 BIFUNCTIONAL
METHYLENETETRAHYDROF
OLATE
DEHYDROGENASE/CYCLOH
YDROLASE,
MITOCHONDRIAL


(Homo sapiens)
PF00763
(THF_DHG_CYH)
PF02882
(THF_DHG_CYH_C)
5 ALA A 269
VAL A 298
ILE A 305
ILE A 251
ILE A 265
None
0.84A 3nujA-5tc4A:
undetectable
3nujA-5tc4A:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2w SHORT CHAIN
DEHYDROGENASE


(Burkholderia
cenocepacia)
PF00106
(adh_short)
5 ALA A  58
VAL A  47
ILE A  35
ILE A  87
ILE A  51
None
0.98A 3nujA-5u2wA:
undetectable
3nujA-5u2wA:
17.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wu7 UNCHARACTERIZED
PROTEIN


(Pyrococcus
horikoshii)
PF03065
(Glyco_hydro_57)
PF09210
(DUF1957)
5 ALA A 259
ILE A 387
GLY A 180
ILE A 181
VAL A 222
None
0.98A 3nujA-5wu7A:
undetectable
3nujA-5wu7A:
11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ww1 PULULLANASE

(Paenibacillus
barengoltzii)
no annotation 6 ALA A 179
VAL A 486
GLY A 369
ILE A 397
VAL A 483
ILE A 530
None
1.27A 3nujA-5ww1A:
undetectable
3nujA-5ww1A:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b3e CYCLIN-DEPENDENT
KINASE 12


(Homo sapiens)
no annotation 5 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
None
1.00A 3nujA-6b3eA:
undetectable
3nujA-6b3eA:
21.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
None
None
None
0.61A 3nujA-6upjA:
17.9
3nujA-6upjA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
5 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
NIU  A 100 (-2.8A)
NIU  A 100 (-3.6A)
NIU  A 100 ( 3.8A)
None
None
0.72A 3nujA-6upjA:
17.9
3nujA-6upjA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 ASP E 215
GLY E 217
VAL E 222
GLY E  76
ILE E 300
None
0.72A 3nujB-1cziE:
6.7
3nujB-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1czi CHYMOSIN

(Bos taurus)
PF00026
(Asp)
5 LEU E  30
ASP E  32
GLY E  34
ASP E  37
ILE E 120
None
0.57A 3nujB-1cziE:
6.7
3nujB-1cziE:
17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1deu PROCATHEPSIN X

(Homo sapiens)
PF00112
(Peptidase_C1)
6 LEU A  57
GLY A  87
ALA A  83
ASP A  81
GLY A 130
ILE A 241
None
1.26A 3nujB-1deuA:
undetectable
3nujB-1deuA:
16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ek6 UDP-GALACTOSE
4-EPIMERASE


(Homo sapiens)
PF16363
(GDP_Man_Dehyd)
5 LEU A  68
GLY A  90
ALA A  89
ILE A 164
ILE A  67
None
NAI  A 400 (-4.1A)
NAI  A 400 (-3.7A)
None
NAI  A 400 (-3.8A)
0.74A 3nujB-1ek6A:
undetectable
3nujB-1ek6A:
12.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 (-2.8A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
1.21A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 (-2.7A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
1.22A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  84
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
1.12A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  84
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 (-3.6A)
A79  A 800 (-3.8A)
1.15A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 3.8A)
A79  A 800 (-2.7A)
A79  A 800 (-3.0A)
A79  A 800 (-3.1A)
A79  A 800 ( 4.9A)
A79  A 800 ( 4.4A)
A79  A 800 ( 3.7A)
A79  A 800 (-3.8A)
A79  A 800 (-3.6A)
0.38A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hvc HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
A79  A 800 ( 4.0A)
A79  A 800 (-2.8A)
A79  A 800 (-3.0A)
A79  A 800 (-3.2A)
A79  A 800 ( 4.7A)
A79  A 800 ( 4.3A)
A79  A 800 (-3.4A)
A79  A 800 ( 4.0A)
A79  A 800 (-3.8A)
0.42A 3nujB-1hvcA:
13.9
3nujB-1hvcA:
46.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ig8 HEXOKINASE PII

(Saccharomyces
cerevisiae)
PF00349
(Hexokinase_1)
PF03727
(Hexokinase_2)
5 LEU A  41
GLY A 399
ALA A 401
ILE A 453
ILE A 438
None
0.91A 3nujB-1ig8A:
undetectable
3nujB-1ig8A:
11.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kae HISTIDINOL
DEHYDROGENASE


(Escherichia
coli)
PF00815
(Histidinol_dh)
5 GLY A 227
ALA A 228
ASP A 204
GLY A 196
ILE A 206
None
0.88A 3nujB-1kaeA:
undetectable
3nujB-1kaeA:
11.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kng THIOL:DISULFIDE
INTERCHANGE PROTEIN
CYCY


(Bradyrhizobium
japonicum)
PF08534
(Redoxin)
5 LEU A  57
ASP A 142
GLY A 145
GLY A 152
ILE A 116
None
0.91A 3nujB-1kngA:
undetectable
3nujB-1kngA:
24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l5j ACONITATE HYDRATASE
2


(Escherichia
coli)
PF00330
(Aconitase)
PF06434
(Aconitase_2_N)
PF11791
(Aconitase_B_N)
5 GLY A 721
ALA A 720
GLY A 715
ILE A 714
ILE A 707
None
0.83A 3nujB-1l5jA:
undetectable
3nujB-1l5jA:
9.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lk5 D-RIBOSE-5-PHOSPHATE
ISOMERASE


(Pyrococcus
horikoshii)
PF06026
(Rib_5-P_isom_A)
5 GLY A 101
ALA A 102
GLY A 207
ILE A  97
ILE A 179
CL  A1001 (-3.4A)
None
None
None
None
0.93A 3nujB-1lk5A:
undetectable
3nujB-1lk5A:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mpp PEPSIN

(Rhizomucor
pusillus)
PF00026
(Asp)
5 LEU A  30
ASP A  32
GLY A  34
ASP A  37
ILE A 120
None
0.75A 3nujB-1mppA:
7.1
3nujB-1mppA:
13.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o5w AMINE OXIDASE
[FLAVIN-CONTAINING]
A


(Rattus
norvegicus)
PF01593
(Amino_oxidase)
5 LEU A 233
ALA A  29
VAL A 238
GLY A  22
ILE A  23
None
None
None
FAD  A 652 (-3.4A)
FAD  A 652 (-4.8A)
0.92A 3nujB-1o5wA:
undetectable
3nujB-1o5wA:
12.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pix GLUTACONYL-COA
DECARBOXYLASE A
SUBUNIT


(Acidaminococcus
fermentans)
PF01039
(Carboxyl_trans)
5 LEU A 146
GLY A 189
ALA A 211
GLY A 252
ILE A 187
None
0.90A 3nujB-1pixA:
undetectable
3nujB-1pixA:
11.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1q9p HIV-1 PROTEASE

(Homo sapiens)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
0.49A 3nujB-1q9pA:
10.1
3nujB-1q9pA:
98.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.24A 3nujB-1sivA:
18.3
3nujB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1siv SIV PROTEASE

(Simian
immunodeficiency
virus)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
0.48A 3nujB-1sivA:
18.3
3nujB-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1suu DNA GYRASE SUBUNIT A

(Borreliella
burgdorferi)
PF03989
(DNA_gyraseA_C)
6 GLY A 780
ALA A 779
VAL A 805
GLY A 722
ILE A 792
ILE A 765
None
1.44A 3nujB-1suuA:
undetectable
3nujB-1suuA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1t8h YLMD PROTEIN
SEQUENCE HOMOLOGUE


(Geobacillus
stearothermophilus)
PF02578
(Cu-oxidase_4)
6 LEU A 140
GLY A  26
ALA A  25
GLY A  16
ILE A   4
ILE A 267
None
1.47A 3nujB-1t8hA:
undetectable
3nujB-1t8hA:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v5f PYRUVATE OXIDASE

(Aerococcus
viridans)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
5 ASP A 388
ALA A 444
ASP A 442
VAL A 466
ILE A 440
None
TPP  A1602 (-3.7A)
MG  A1603 ( 2.8A)
None
None
0.93A 3nujB-1v5fA:
undetectable
3nujB-1v5fA:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bc0 NADH OXIDASE

(Streptococcus
pyogenes)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 GLY A 453
ALA A 454
ASP A 456
ILE A 387
ILE A 426
None
0.61A 3nujB-2bc0A:
undetectable
3nujB-2bc0A:
12.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cvj THIOREDOXIN
REDUCTASE RELATED
PROTEIN


(Thermus
thermophilus)
PF00890
(FAD_binding_2)
PF07992
(Pyr_redox_2)
5 LEU A 170
GLY A  24
ALA A  23
ASP A 177
VAL A 164
None
0.94A 3nujB-2cvjA:
undetectable
3nujB-2cvjA:
18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dws COPPER-CONTAINING
NITRITE REDUCTASE


(Rhodobacter
sphaeroides)
PF00394
(Cu-oxidase)
PF07732
(Cu-oxidase_3)
5 LEU A  90
GLY A 254
ALA A 255
GLY A 347
ILE A 250
None
0.85A 3nujB-2dwsA:
undetectable
3nujB-2dwsA:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ewn BIRA BIFUNCTIONAL
PROTEIN


(Escherichia
coli)
PF02237
(BPL_C)
PF03099
(BPL_LplA_LipB)
PF08279
(HTH_11)
6 LEU A 131
GLY A 186
ALA A 185
GLY A 154
ILE A 153
ILE A 207
None
BTX  A 501 (-3.3A)
None
None
None
None
1.10A 3nujB-2ewnA:
undetectable
3nujB-2ewnA:
19.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
6 ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  54
ILE A  89
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.6A)
LP1  A 201 (-4.2A)
0.77A 3nujB-2fmbA:
14.9
3nujB-2fmbA:
34.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2fmb EQUINE INFECTIOUS
ANEMIA VIRUS
PROTEASE


(Equine
infectious
anemia virus)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  55
ILE A  89
None
LP1  A 201 (-2.3A)
LP1  A 201 (-3.8A)
LP1  A 201 (-3.5A)
None
LP1  A 201 (-3.4A)
LP1  A 201 (-4.2A)
0.36A 3nujB-2fmbA:
14.9
3nujB-2fmbA:
34.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iny HEXON PROTEIN

(Fowl
aviadenovirus A)
PF01065
(Adeno_hexon)
PF03678
(Adeno_hexon_C)
5 GLY A 184
ALA A 194
ASP A 195
ILE A 174
ILE A 199
None
0.91A 3nujB-2inyA:
undetectable
3nujB-2inyA:
6.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3e DIAMINOPIMELATE
DECARBOXYLASE


(Aquifex
aeolicus)
PF00278
(Orn_DAP_Arg_deC)
PF02784
(Orn_Arg_deC_N)
5 ALA A 355
VAL A 371
GLY A 345
ILE A 308
ILE A 328
None
0.92A 3nujB-2p3eA:
undetectable
3nujB-2p3eA:
11.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ph3 3-OXOACYL-[ACYL
CARRIER PROTEIN]
REDUCTASE


(Thermus
thermophilus)
PF13561
(adh_short_C2)
5 LEU A  28
GLY A  14
ALA A   9
VAL A  56
ILE A  30
None
0.87A 3nujB-2ph3A:
undetectable
3nujB-2ph3A:
18.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qjc DIADENOSINE
TETRAPHOSPHATASE,
PUTATIVE


(Trypanosoma
brucei)
PF00149
(Metallophos)
5 LEU A  14
GLY A  19
VAL A 137
ILE A  22
ILE A 132
None
0.93A 3nujB-2qjcA:
undetectable
3nujB-2qjcA:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ri6 2-HYDROXY-6-OXO-6-PH
ENYLHEXA-2,4-DIENOAT
E HYDROLASE


(Paraburkholderia
xenovorans)
PF12697
(Abhydrolase_6)
5 LEU A 283
GLY A  63
ALA A  62
GLY A  57
ILE A 280
None
0.72A 3nujB-2ri6A:
undetectable
3nujB-2ri6A:
15.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.5A)
AB1  A 501 ( 3.3A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
1.32A 3nujB-2rkfA:
20.1
3nujB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rkf PROTEASE RETROPEPSIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
AB1  A 501 (-2.4A)
AB1  A 501 (-3.9A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 (-3.5A)
AB1  A 501 (-3.8A)
AB1  A 501 ( 4.2A)
0.40A 3nujB-2rkfA:
20.1
3nujB-2rkfA:
82.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2rsp RSV PROTEASE

(Rous sarcoma
virus)
PF00077
(RVP)
5 LEU A  35
ASP A  37
GLY A  39
ALA A  40
ILE A 108
None
0.39A 3nujB-2rspA:
12.7
3nujB-2rspA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vdc GLUTAMATE SYNTHASE
[NADPH] LARGE CHAIN


(Azospirillum
brasilense)
PF00310
(GATase_2)
PF01493
(GXGXG)
PF01645
(Glu_synthase)
PF04898
(Glu_syn_central)
6 LEU A1286
GLY A1273
ALA A1272
ASP A1291
VAL A1307
GLY A1324
None
1.42A 3nujB-2vdcA:
undetectable
3nujB-2vdcA:
6.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wsk GLYCOGEN DEBRANCHING
ENZYME


(Escherichia
coli)
PF00128
(Alpha-amylase)
PF02922
(CBM_48)
5 LEU A 188
GLY A 255
ALA A 254
ILE A 248
ILE A 185
None
0.77A 3nujB-2wskA:
undetectable
3nujB-2wskA:
8.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yfq NAD-SPECIFIC
GLUTAMATE
DEHYDROGENASE


(Peptoniphilus
asaccharolyticus)
PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N)
6 LEU A 317
ALA A 213
ASP A 212
GLY A 236
ILE A 231
ILE A 208
None
1.24A 3nujB-2yfqA:
undetectable
3nujB-2yfqA:
14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yv3 ASPARTATE-SEMIALDEHY
DE DEHYDROGENASE


(Thermus
thermophilus)
PF01118
(Semialdhyde_dh)
PF02774
(Semialdhyde_dhC)
5 LEU A 259
GLY A 264
VAL A 268
GLY A 309
ILE A 129
None
0.94A 3nujB-2yv3A:
undetectable
3nujB-2yv3A:
16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gf7 GLUTACONYL-COA
DECARBOXYLASE
SUBUNIT A


([Clostridium]
symbiosum)
PF01039
(Carboxyl_trans)
5 LEU A 148
GLY A 191
ALA A 213
GLY A 256
ILE A 189
None
0.85A 3nujB-3gf7A:
undetectable
3nujB-3gf7A:
10.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i4o TRANSLATION
INITIATION FACTOR
IF-1


(Mycobacterium
tuberculosis)
PF01176
(eIF-1a)
5 LEU A  27
GLY A  66
ALA A  35
VAL A  14
ILE A  25
None
0.90A 3nujB-3i4oA:
undetectable
3nujB-3i4oA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i5g MYOSIN HEAVY CHAIN
ISOFORM A


(Doryteuthis
pealeii)
PF00063
(Myosin_head)
PF00612
(IQ)
PF02736
(Myosin_N)
5 GLY A 264
ALA A 265
GLY A 460
ILE A 459
ILE A 224
None
0.93A 3nujB-3i5gA:
undetectable
3nujB-3i5gA:
7.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iha SALT-TOLERANT
GLUTAMINASE


(Micrococcus
luteus)
PF04960
(Glutaminase)
5 LEU A  12
GLY A 291
GLY A 267
ILE A 255
ILE A  41
None
0.92A 3nujB-3ihaA:
undetectable
3nujB-3ihaA:
12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3khz PUTATIVE DIPEPTIDASE
SACOL1801


(Staphylococcus
aureus)
PF01546
(Peptidase_M20)
5 LEU A 130
GLY A  73
ALA A  72
GLY A  80
ILE A 127
None
0.93A 3nujB-3khzA:
undetectable
3nujB-3khzA:
12.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kl7 PUTATIVE
METAL-DEPENDENT
HYDROLASE


(Parabacteroides
distasonis)
PF13483
(Lactamase_B_3)
5 LEU A 156
GLY A 153
ASP A 120
ILE A  77
ILE A 130
None
0.85A 3nujB-3kl7A:
undetectable
3nujB-3kl7A:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lad DIHYDROLIPOAMIDE
DEHYDROGENASE


(Azotobacter
vinelandii)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 LEU A 239
GLY A 187
ALA A 188
GLY A 196
ILE A 238
None
0.94A 3nujB-3ladA:
undetectable
3nujB-3ladA:
12.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdo PUTATIVE
PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
CYCLO-LIGASE


(Parabacteroides
distasonis)
PF02769
(AIRS_C)
6 LEU A 251
GLY A 256
ALA A 255
ASP A 246
ILE A 319
ILE A 248
None
1.07A 3nujB-3mdoA:
undetectable
3nujB-3mdoA:
14.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
None
0.83A 3nujB-3mwsA:
19.5
3nujB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.25A 3nujB-3mwsA:
19.5
3nujB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
0.51A 3nujB-3mwsA:
19.5
3nujB-3mwsA:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3mws HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
0.40A 3nujB-3mwsA:
19.5
3nujB-3mwsA:
78.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pdx TYROSINE
AMINOTRANSFERASE


(Mus musculus)
PF00155
(Aminotran_1_2)
5 LEU A 331
GLY A 325
ALA A 326
VAL A  93
ILE A 330
None
0.91A 3nujB-3pdxA:
undetectable
3nujB-3pdxA:
14.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3si9 DIHYDRODIPICOLINATE
SYNTHASE


(Bartonella
henselae)
PF00701
(DHDPS)
5 GLY A  80
ALA A  79
VAL A  68
ILE A 130
ILE A  64
None
0.92A 3nujB-3si9A:
undetectable
3nujB-3si9A:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slz GAG-PRO-POL
POLYPROTEIN


(Murine leukemia
virus)
PF00077
(RVP)
6 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  56
None
3TL  A 126 (-2.4A)
3TL  A 126 (-3.1A)
3TL  A 126 ( 4.0A)
None
3TL  A 126 (-3.4A)
0.46A 3nujB-3slzA:
11.4
3nujB-3slzA:
25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t2y SULFIDE-QUINONE
REDUCTASE, PUTATIVE


(Acidithiobacillus
ferrooxidans)
PF07992
(Pyr_redox_2)
5 LEU A   7
GLY A 106
ALA A 303
GLY A 281
ILE A 103
FAD  A 500 (-4.7A)
FAD  A 500 (-3.1A)
None
None
None
0.72A 3nujB-3t2yA:
undetectable
3nujB-3t2yA:
12.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.5A)
017  A 201 (-3.5A)
017  A 201 (-4.0A)
017  A 201 (-3.3A)
1.37A 3nujB-3t3cA:
18.3
3nujB-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3t3c HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
SO4  A 101 (-4.2A)
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.5A)
017  A 201 (-4.2A)
None
017  A 201 (-4.0A)
017  A 201 (-3.3A)
0.40A 3nujB-3t3cA:
18.3
3nujB-3t3cA:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
017  A 201 (-2.6A)
017  A 201 (-3.4A)
017  A 201 (-3.3A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
1.23A 3nujB-3ttpA:
19.2
3nujB-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ttp HIV-1 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
017  A 201 (-2.6A)
017  A 201 (-3.6A)
017  A 201 (-3.4A)
017  A 201 (-4.6A)
017  A 201 (-3.0A)
017  A 201 (-3.3A)
017  A 201 (-4.7A)
0.45A 3nujB-3ttpA:
19.2
3nujB-3ttpA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 (-3.4A)
017  A 201 (-3.2A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
1.27A 3nujB-3u7sA:
19.7
3nujB-3u7sA:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3u7s POL POLYPROTEIN

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
None
017  A 202 ( 2.5A)
017  A 201 ( 3.5A)
017  A 201 (-3.4A)
017  A 201 ( 4.0A)
017  A 202 (-2.9A)
017  A 201 ( 3.5A)
0.23A 3nujB-3u7sA:
19.7
3nujB-3u7sA:
76.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3umm PHOSPHORIBOSYLFORMYL
GLYCINAMIDINE
SYNTHASE


(Salmonella
enterica)
PF02769
(AIRS_C)
PF13507
(GATase_5)
6 LEU A 498
GLY A 433
ALA A 580
VAL A 516
GLY A 578
ILE A 430
None
1.33A 3nujB-3ummA:
undetectable
3nujB-3ummA:
6.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uzu RIBOSOMAL RNA SMALL
SUBUNIT
METHYLTRANSFERASE A


(Burkholderia
pseudomallei)
PF00398
(RrnaAD)
5 LEU A  88
GLY A  48
VAL A  56
GLY A 116
ILE A  45
None
0.87A 3nujB-3uzuA:
undetectable
3nujB-3uzuA:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4emw COENZYME A DISULFIDE
REDUCTASE


(Staphylococcus
aureus)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
5 LEU A 109
GLY A   8
GLY A 276
ILE A 278
ILE A 110
None
FAD  A 501 (-3.1A)
FAD  A 501 (-3.2A)
None
None
0.94A 3nujB-4emwA:
undetectable
3nujB-4emwA:
13.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g6c BETA-HEXOSAMINIDASE
1


(Burkholderia
cenocepacia)
PF00933
(Glyco_hydro_3)
5 ASP A 128
GLY A 174
VAL A 136
ILE A 215
ILE A 137
None
0.86A 3nujB-4g6cA:
undetectable
3nujB-4g6cA:
15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4inj LMO1638 PROTEIN

(Listeria
monocytogenes)
PF02016
(Peptidase_S66)
5 LEU A 162
ALA A 309
GLY A 306
ILE A 305
ILE A 321
None
0.87A 3nujB-4injA:
undetectable
3nujB-4injA:
15.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 ALA A  28
ASP A  30
VAL A  32
GLY A  48
ILE A  84
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.8A)
RIT  A 500 (-4.3A)
0.81A 3nujB-4njvA:
19.8
3nujB-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.6A)
RIT  A 500 (-3.2A)
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
1.25A 3nujB-4njvA:
19.8
3nujB-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
7 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
RIT  A 500 (-4.8A)
None
RIT  A 500 (-4.3A)
0.45A 3nujB-4njvA:
19.8
3nujB-4njvA:
85.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4njv PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
RIT  A 500 (-2.4A)
RIT  A 500 (-3.9A)
RIT  A 500 (-3.6A)
None
RIT  A 500 (-3.4A)
RIT  A 500 (-4.3A)
RIT  A 500 (-4.3A)
0.34A 3nujB-4njvA:
19.8
3nujB-4njvA:
85.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pyr PUTATIVE
BRANCHED-CHAIN AMINO
ACID ABC TRANSPORTER


(Chromobacterium
violaceum)
PF04348
(LppC)
5 LEU A 166
VAL A  88
GLY A 107
ILE A 337
ILE A 146
None
0.79A 3nujB-4pyrA:
undetectable
3nujB-4pyrA:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qi6 CELLOBIOSE
DEHYDROGENASE


(Crassicarpon
hotsonii)
PF00732
(GMC_oxred_N)
PF00734
(CBM_1)
PF05199
(GMC_oxred_C)
PF16010
(CDH-cyt)
5 LEU A 489
GLY A 481
ALA A 480
ILE A 477
ILE A 488
None
FAD  A 902 (-3.6A)
FAD  A 902 (-3.9A)
None
None
0.93A 3nujB-4qi6A:
undetectable
3nujB-4qi6A:
8.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qpn PROTEIN-LYSINE
METHYLTRANSFERASE
METTL21B


(Homo sapiens)
PF10294
(Methyltransf_16)
5 LEU A 109
GLY A  83
ALA A  84
ILE A  80
ILE A 112
None
SAH  A 301 (-3.6A)
None
None
None
0.73A 3nujB-4qpnA:
undetectable
3nujB-4qpnA:
19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tnb G PROTEIN-COUPLED
RECEPTOR KINASE 5


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
5 LEU A  45
ASP A  52
GLY A  63
ILE A  62
ILE A  49
None
0.92A 3nujB-4tnbA:
undetectable
3nujB-4tnbA:
11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xib E3 UBIQUITIN-PROTEIN
LIGASE MIB1


(Homo sapiens)
PF00569
(ZZ)
PF06701
(MIB_HERC2)
6 LEU A 215
GLY A 154
ALA A 155
ASP A 220
GLY A 223
ILE A 151
None
1.48A 3nujB-4xibA:
undetectable
3nujB-4xibA:
13.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xll DJ-1 FAMILY PROTEIN

(Toxoplasma
gondii)
PF01965
(DJ-1_PfpI)
5 LEU A 168
GLY A  29
ALA A  28
ILE A  22
ILE A 165
None
0.82A 3nujB-4xllA:
undetectable
3nujB-4xllA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xr9 CALS8

(Micromonospora
echinospora)
PF00984
(UDPG_MGDP_dh)
PF03720
(UDPG_MGDP_dh_C)
PF03721
(UDPG_MGDP_dh_N)
5 ASP A 248
VAL A 249
GLY A 452
ILE A 451
ILE A 250
None
0.92A 3nujB-4xr9A:
undetectable
3nujB-4xr9A:
14.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ydf HTLV-1 PROTEASE

(Primate
T-lymphotropic
virus 1)
PF00077
(RVP)
7 LEU A  30
ASP A  32
GLY A  34
ALA A  35
VAL A  39
GLY A  58
ILE A 100
None
4B1  A 201 (-2.9A)
4B1  A 201 ( 4.6A)
4B1  A 201 (-3.6A)
None
4B1  A 201 (-3.4A)
4B1  A 201 (-4.8A)
0.58A 3nujB-4ydfA:
12.7
3nujB-4ydfA:
32.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yzg PROTEIN PHOSPHATASE
2C 57


(Arabidopsis
thaliana)
PF00481
(PP2C)
5 ASP A 238
GLY A 160
GLY A 179
ILE A 178
ILE A 230
None
0.92A 3nujB-4yzgA:
undetectable
3nujB-4yzgA:
15.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b18 PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
5 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
None
0.86A 3nujB-5b18A:
18.1
3nujB-5b18A:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cvw BIFUNCTIONAL
HEMOLYSIN/ADENYLATE
CYCLASE


(Bordetella
pertussis)
PF00353
(HemolysinCabind)
PF06594
(HCBP_related)
6 LEU A1634
GLY A1616
ALA A1615
VAL A1594
ILE A1656
ILE A1633
GOL  A1711 ( 4.3A)
None
None
None
None
None
1.49A 3nujB-5cvwA:
undetectable
3nujB-5cvwA:
20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw2 PUTATIVE EPOXIDE
HYDROLASE EPHA


(Mycolicibacterium
thermoresistibile)
no annotation 5 LEU C 315
GLY C  53
ALA C  52
ILE C  46
ILE C 312
None
0.80A 3nujB-5cw2C:
undetectable
3nujB-5cw2C:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw5 BRCA1/BRCA2-CONTAINI
NG COMPLEX SUBUNIT 3


(Camponotus
floridanus)
PF01398
(JAB)
5 LEU A  79
VAL A  89
GLY A  33
ILE A  51
ILE A  36
None
0.92A 3nujB-5cw5A:
undetectable
3nujB-5cw5A:
14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ej1 PUTATIVE CELLULOSE
SYNTHASE


(Rhodobacter
sphaeroides)
PF00535
(Glycos_transf_2)
PF03552
(Cellulose_synt)
PF07238
(PilZ)
5 LEU A 688
GLY A 614
VAL A 681
GLY A 655
ILE A 637
None
C2E  A 919 (-3.4A)
None
None
None
0.79A 3nujB-5ej1A:
undetectable
3nujB-5ej1A:
8.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ema SORTING NEXIN-27

(Rattus
norvegicus)
PF00595
(PDZ)
5 LEU A 130
GLY A  94
ALA A  93
GLY A  88
ILE A  46
None
0.93A 3nujB-5emaA:
undetectable
3nujB-5emaA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g5g PUTATIVE XANTHINE
DEHYDROGENASE YAGT
IRON-SULFUR-BINDING
SUBUNIT


(Escherichia
coli)
PF00111
(Fer2)
PF01799
(Fer2_2)
5 GLY A 211
ALA A 212
ASP A 154
GLY A 159
ILE A 216
None
None
None
FES  A 230 (-4.2A)
None
0.87A 3nujB-5g5gA:
undetectable
3nujB-5g5gA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5irp ALANINE RACEMASE 2

(Bacillus
subtilis)
PF00842
(Ala_racemase_C)
PF01168
(Ala_racemase_N)
5 GLY A  77
ALA A  76
GLY A  70
ILE A  82
ILE A  48
None
0.91A 3nujB-5irpA:
undetectable
3nujB-5irpA:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5it1 PUTATIVE CYTOCHROME
P450


(Streptomyces
peucetius)
PF00067
(p450)
5 ALA A 238
VAL A 150
GLY A 350
ILE A 349
ILE A 151
HEM  A 401 (-3.1A)
None
HEM  A 401 ( 3.7A)
HEM  A 401 (-4.4A)
None
0.89A 3nujB-5it1A:
undetectable
3nujB-5it1A:
13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jxk ASP/GLU-SPECIFIC
DIPEPTIDYL-PEPTIDASE


(Porphyromonas
endodontalis)
PF10459
(Peptidase_S46)
5 GLY A 583
ALA A 594
VAL A 263
ILE A 689
ILE A 581
None
0.94A 3nujB-5jxkA:
undetectable
3nujB-5jxkA:
8.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
6 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
None
1.25A 3nujB-5t2zA:
19.9
3nujB-5t2zA:
81.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t2z PROTEASE

(Human
immunodeficiency
virus 1)
PF00077
(RVP)
9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  32
GLY A  49
ILE A  50
ILE A  84
None
0.41A 3nujB-5t2zA:
19.9
3nujB-5t2zA:
81.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wgx FLAVIN-DEPENDENT
HALOGENASE


(Malbranchea
aurantiaca)
PF04820
(Trp_halogenase)
5 LEU A  64
VAL A 160
GLY A  49
ILE A 397
ILE A  66
None
0.93A 3nujB-5wgxA:
undetectable
3nujB-5wgxA:
12.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5z2e DIHYDRODIPICOLINATE
REDUCTASE


(Paenisporosarcina
sp. TG-14)
no annotation 6 GLY A 259
ALA A 124
VAL A  96
GLY A 242
ILE A 129
ILE A 122
None
1.40A 3nujB-5z2eA:
undetectable
3nujB-5z2eA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ei3 PROTON-DEPENDENT
OLIGOPEPTIDE
TRANSPORTER FAMILY
PROTEIN


(Xanthomonas
campestris)
no annotation 5 LEU A 173
ALA A 186
GLY A 191
ILE A 192
ILE A 174
None
None
None
78M  A 603 (-4.3A)
None
0.93A 3nujB-6ei3A:
undetectable
3nujB-6ei3A:
12.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6fiv RETROPEPSIN

(Feline
immunodeficiency
virus)
PF00077
(RVP)
5 LEU A  28
ASP A  30
GLY A  32
ALA A  33
GLY A  58
None
3TL  A 201 (-3.5A)
3TL  A 201 (-3.4A)
3TL  A 201 (-4.0A)
3TL  A 201 (-3.4A)
0.20A 3nujB-6fivA:
15.6
3nujB-6fivA:
30.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6grw -

(-)
no annotation 5 LEU A 247
GLY A 277
ALA A 276
GLY A 265
ILE A 287
None
0.94A 3nujB-6grwA:
undetectable
3nujB-6grwA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6upj HIV-2 PROTEASE

(Human
immunodeficiency
virus 2)
PF00077
(RVP)
8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
None
NIU  A 100 (-2.8A)
NIU  A 100 (-4.5A)
NIU  A 100 (-3.6A)
None
NIU  A 100 ( 3.8A)
NIU  A 100 (-3.9A)
None
0.70A 3nujB-6upjA:
17.5
3nujB-6upjA:
48.48